With so much still uncertain about life after the coronavirus, the development and distribution of vaccines across the world provide hope for a COVID-free future. The Jiangsu Province has announced plans to vaccinate 56 million people against COVID-19 by the end of the year,^[1] and the Jiangsu Educational Department hopes to vaccinate university students by the end of April. So far, DKU students and faculty have been given three opportunities to receive the vaccine, on March 23rd, April 8th, and April 9th. These provided the first dose of a two-shot vaccine, with the second administration coming two to eight weeks later, though these appointments have yet to be scheduled. It is said that later vaccines will require three rounds of administration instead of the current two. DKU provides shuttles to clinics offering the vaccine, and it is provided at no charge. However, many members of the DKU community have still not been able to receive their shot due to limited supplies in clinics, which often run out in the second half of the day. It should also be noted that, at this stage, vaccines for students and faculty are optional.

China has approved four vaccines for use and distributed 216 million vaccines as of April 23rd,^[2] with about 16 per 100 people vaccinated.^[3] Three of the approved vaccines are inactivated virus vaccines, using a “dead” form of the coronavirus to help the body build immunity. The fourth is a “viral vector vaccine”, which uses a different virus to enter the cell and create a harmless form of COVID-19. There is also mention of China developing its own mRNA vaccine, similar to the Pfizer and Moderna vaccines used in the United States and Europe.^[4] Globally,